Marvell Technology, Inc. (MRVL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 236.1 |
| Open | 216.04 |
| Day High | 224.1 |
| Day Low | 213.63 |
| 52-Week High | 329.88 |
| 52-Week Low | 66.33 |
| Volume | 21.96M |
| Average Volume | 31.25M |
| Market Cap | 191.64B |
| PE | 66.31 |
| EPS | 3.3 |
| Moving Average 50 Days | 216.85 |
| Moving Average 200 Days | 154.82 |
| Change | -17.28 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX